Client:

A leading US Pharma company

Challenge:

Identify cardiotoxic hERG binding molecules in proprietary database.

Strand’s Solution:

We devised a model that identified 94% of binders in a proprietary dataset of compounds. We also packaged the model for deployment in the customer's IT system. Through Strand's expertise, the client was able to save cost and also gain effective in silico compound prioritization.